Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Sulfo-NHS-SS-Biotin: Practical Labeling Guide
2026-08-31
Sulfo-NHS-SS-Biotin labels accessible primary amines in aqueous protein or intact-cell-surface workflows, supporting avidin/streptavidin capture and reduction-based label removal. It should be prepared fresh and used promptly, and it is not intended for intracellular labeling of intact, nonpermeabilized cells.
-
Resiquimod (R-848) in Thermal Ablation Research
2026-08-31
Resiquimod (R-848) connects local tumor ablation with innate immune response modulation by activating TLR7/8, dendritic cells, and macrophages. This practical guide translates a thermal-protective, dual-responsive hydrogel study into assay controls, formulation decisions, and troubleshooting steps for cancer immunotherapy research.
-
CLCC1 and Herpesvirus Nuclear Egress
2026-08-30
A whole-genome CRISPR screen identified CLCC1 as a host factor required for the fusion step of herpesvirus nuclear egress. Loss of CLCC1 traps capsids in perinuclear vesicles, reduces viral production, and also disrupts nuclear pore complex insertion, linking herpesvirus egress to fundamental nuclear-envelope morphogenesis.
-
Fingolimod (FTY720) Assay Reliability Guide
2026-08-29
Learn how to design, optimize, and interpret Fingolimod (FTY720) viability and cytotoxicity experiments using evidence-based concentration, solubility, storage, and control strategies. SKU A8548 provides a documented, high-purity reference material for laboratories comparing S1P signaling effects across cell models.
-
L-NAME Hydrochloride for Vascular Mechanism Studies
2026-08-28
L-NAME Hydrochloride provides a practical NO-synthesis blockade for separating nitric oxide-dependent effects from prostaglandin and receptor-driven vascular responses. This workflow combines concentration-aware assay design, L-arginine rescue, and the rapakinin reference model to improve mechanistic confidence in hypertension research and cell studies.
-
EDC.HCl Practical Coupling Workflow
2026-08-28
EDC.HCl is a water-soluble carbodiimide for activating carboxyl groups before amide bond formation with primary amines in peptide synthesis and bioconjugation workflows. It is suitable for controlled in vitro laboratory use, but the available dossier provides no in vivo, clinical, or substrate-pair-specific validation.
-
Hoechst 33342/PI Double Staining Kit: Practical Guide
2026-08-27
The Hoechst 33342/PI Double Staining Kit (SKU K2237) provides a dual-fluorescence approach for comparing nuclear chromatin changes with loss of cell membrane integrity in apoptosis and necrosis studies. It is intended for scientific research workflows, not diagnostic or medical use, and should be interpreted with appropriate controls rather than as a standalone classification method.
-
Torin2: Selective mTOR Inhibitor for Cancer Research
2026-08-27
Torin2 is a potent, selective, orally available mTOR inhibitor with a reported EC50 of 0.25 nM. Its cellular, formulation, and in vivo profiles support mechanistic cancer research, including studies of medullary thyroid carcinoma models, while experimental interpretation requires orthogonal viability and apoptosis readouts.
-
VE-821: ATR Checkpoints and Viral DNA Assays
2026-08-26
VE-821 is a selective ATR kinase inhibitor for dissecting replication-stress signaling, radiosensitization, and DNA repair pathway research. This article develops an assay-centered framework linking ATR checkpoint biology with the DNMT1-dependent replication and RNA-processing logic reported for human bocavirus 1.
-
Carvedilol: β-Blockade, Redox, and HCT Evidence
2026-08-26
Carvedilol is a nonselective β-adrenergic receptor antagonist with additional α1-adrenergic receptor antagonism. Research data support its use in β-adrenergic receptor research, oxidative stress inhibition, vascular smooth muscle studies, and transplant-related mechanistic work, while also defining important limits for dose translation.
-
Cholesterol: From LNP Ingredient to Evidence
2026-08-25
Cholesterol is the principal sterol at the intersection of membrane biophysics and lipid nanoparticle research. This evidence-centered guide shows how to connect cholesterol composition, membrane fluidity assays, localized mRNA delivery, and biological interpretation without confusing formulation effects with therapeutic causality.
-
Tyrothricin: Mechanism and Research Workflow
2026-08-25
Tyrothricin is a peptide antibiotic mixture whose principal research value comes from membrane-focused antimicrobial activity. Its activity should be evaluated with organism-specific controls, fresh solutions, solid storage at −20°C, and separate cytotoxicity and antiviral assays.
-
B7H3×CD3 BiTE mRNA-LNPs in Cancer Therapy
2026-08-24
Huang and colleagues developed an ionizable lipid nanoparticle system for delivering mRNA encoding a B7H3×CD3 bispecific T-cell engager. The study shows how transient in vivo mRNA expression can address manufacturing, exposure, and dosing limitations associated with recombinant BiTE antibodies in preclinical models of hematologic malignancy and melanoma.
-
Exosome-Like Nanovesicles for Oral Mucositis
2026-08-24
Wei et al. developed oridonin-loaded exosome-like nanovesicles from Rabdosia rubescens and embedded them in a semi-interpenetrating network hydrogel for chemoradiotherapy-induced oral mucositis. The composite improved local delivery, antibacterial activity, collagen deposition, and inflammatory control in preclinical models, with NLRP3-associated signaling identified as a mechanistic component.
-
Agatoxin-IVA and Cardiac Vagal Neuron Activation
2026-08-23
Wang, Irnaten, and Mendelowitz identified agatoxin-IVA-sensitive voltage-dependent calcium channels as key mediators of both presynaptic and postsynaptic nicotinic excitation in cardiac vagal neurons. Their patch-clamp pharmacology separates Cav2.1-related signaling from L-type and N/Q-type contributions, providing a useful framework for interpreting calcium-dependent synaptic transmission research.